Understand the source comparison
KPV MC1R Mechanism: Peptide Comparison
KPV MC1R (melanocortin-1 receptor) Blocks NF-κB nuclear translocation via cAMP/PKA pathway, preventing inflammatory cytokine transcription Moderate (60–70% TNF-α reduction at 10–100 μM in vitro) 4–6 hours Best for localized immune modulation in tissues with hi
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- KPV
- MC1R (melanocortin-1 receptor)
- Blocks NF-κB nuclear translocation via cAMP/PKA pathway, preventing inflammatory cytokine transcription
- Moderate (60–70% TNF-α reduction at 10–100 μM in vitro)
- 4–6 hours
- Best for localized immune modulation in tissues with high MC1R density. Intestinal mucosa, skin, specific immune cell types
- BPC-157
- Unknown (proposed VEGF receptor interaction)
- Promotes angiogenesis, stabilizes nitric oxide pathways, accelerates tissue repair
- Low to moderate (indirect anti-inflammatory via healing acceleration)
- 12–24 hours
- Stronger for tissue repair than direct cytokine suppression. Complements rather than replaces KPV
- Thymosin Beta-4
- Actin sequestration, no single receptor
- Regulates actin polymerization, cell migration, angiogenesis
- Low (indirect via wound healing and cell motility)
- 24–48 hours
- Regenerative rather than anti-inflammatory. Affects tissue architecture, not cytokine signaling
- LL-37
- FPR2 (formyl peptide receptor 2)
- Immune modulation, antimicrobial activity, LPS neutralization
- High (direct LPS binding reduces endotoxin-driven inflammation)
- 2–4 hours
- Antimicrobial first, anti-inflammatory second. Stronger acute innate immune effects than KPV